Researchers develop method for evaluating long-term COVID-19 vaccine efficacy

April 27, 2021
The large-scale deployment of effective vaccines is globally recognized as the best way to end the COVID-19 pandemic. However, the high efficacy reported for vaccines currently in use — like Pfizer and Moderna — is based on an average follow-up time of only about two months after the second dose. The question remains: Will people need booster vaccinations?

South African beverage tax has reduced purchases of sugar-sweetened beverages

April 8, 2021
A new study shows that South Africa’s 2018 tax on sugary beverages led to a reduction in purchases of the beverages, which could mean purchasers are consuming less excess sugar and fewer calories.

New ozone air pollution maps support Global Burden of Disease study

March 8, 2021
New research led by UNC Gillings School students and faculty has mapped global ground-level ozone concentrations by year using a data fusion. This is the first time this method has been applied to ozone observations globally. The findings were used by the Global Burden of Disease 2019 study, which estimated that about 365,000 people around the world died in 2019 from exposure to ozone pollution.

The next generation of public health leaders must focus on human rights

March 4, 2021
Twelve students from the University of North Carolina at Chapel Hill teamed up to publish a perspective in the American Journal of Public Health about why and how they — the next generation of public health leaders — must center human rights in their work.

COVID-19 creates challenges and improvements to care for youth with diabetes around the world

March 2, 2021
For pediatric diabetes clinics worldwide, the pivot to telemedicine during the pandemic has been challenging, but it has also presented opportunities for improved care, according to a new study led by Gillings School nutrition researchers.

Regional variations in gut microbiota could contribute to varying health effects in China

February 18, 2021
Regional factors appear to play a significant role in the diversity of gut microbiota and could predict health effects in certain populations, according to the results of a research collaboration between UNC-Chapel Hill, UNC Charlotte and the National Institute for Nutrition and Health in Beijing, China.

Broad spectrum antiviral proves highly effective at preventing, treating COVID-19 infection

February 9, 2021
Using a novel in vivo research model containing human lung tissue, UNC Gillings School of Global Public Health and UNC School of Medicine scientists demonstrated that the experimental drug EIDD-2801 proved dramatically effective at preventing and treating SARS-CoV-2 infection.

New WHO resources leverage Gillings expertise to improve quality of care worldwide

February 8, 2021
With the need for quality health care more acute than ever, Gillings Global Advisor Sheila Leatherman and researchers at the Gillings School have collaborated with the World Health Organization to develop a set of resources that can help health and humanitarian agencies design an approach to quality care delivery in fragile, conflict-affected and vulnerable settings.

Study finds no negative economic impact from Chilean food labeling and advertising law

January 26, 2021
New research from the Global Food Research Program at UNC-Chapel Hill finds that the food and beverage sector in Chile did not face significant job losses or wage decreases 18 months after implementation of its food labeling and advertising law.

Addressing pandemic problems

January 19, 2021
While COVID-19 has shaken the world, it has also pushed society to be more innovative and creative — two attributes that have been essential to the success of researchers at UNC. Carolina students, faculty and staff are engaged in an abundance of projects, making UNC the most cited university in the United States for coronavirus research.

Visit our communications and marketing team page.
Contact with any media inquiries or general questions.

Communications and Marketing Office
125 Rosenau Hall
CB #7400
135 Dauer Drive
Chapel Hill, NC 27599-7400